Login
Home
Charts
Search
Watchlist
Products

Axel Polymers Ltd

AXELPOLY·BSE
46.50+2.99%Wed, 23 Sept '26

Axel Polymers Ltd

AXELPOLY
BSE
46.50
+2.99%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
51Cr
Close
Close Price
46.50
Industry
Industry
Plastics - Masterbatches
PE
Price To Earnings
PS
Price To Sales
1.05
Revenue
Revenue
49Cr
Rev Gr TTM
Revenue Growth TTM
-4.14%
PAT Gr TTM
PAT Growth TTM
-278.57%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
31393742141114121191316
Growth YoY
Revenue Growth YoY%
44.1117.937.263.7-55.1-71.3-61.6-72.3-22.7-20.3-8.438.5
Expenses
ExpensesCr
30373642141111111091315
Operating Profit
Operating ProfitCr
111000311001
OPM
OPM%
4.53.83.80.71.11.423.08.68.73.21.86.5
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
111111111111
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
110-1-1-1200-1-10
Tax
TaxCr
001000000000
PAT
PATCr
110-1-1-1200-1-10
Growth YoY
PAT Growth YoY%
100.0148.2-117.1-185.5-262.0-213.43,285.7107.5101.218.4-136.8350.0
NPM
NPM%
1.61.7-0.2-1.3-5.8-6.815.60.30.1-7.0-6.31.1
EPS
EPS
0.60.8-0.1-0.6-0.9-0.92.60.10.0-0.1-0.80.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
31393742141114121191316
Growth YoY
Revenue Growth YoY%
44.1117.937.263.7-55.1-71.3-61.6-72.3-22.7-20.3-8.438.5
Expenses
ExpensesCr
30373642141111111091315
Operating Profit
Operating ProfitCr
111000311001
OPM
OPM%
4.53.83.80.71.11.423.08.68.73.21.86.5
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
111111111111
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
110-1-1-1200-1-10
Tax
TaxCr
001000000000
PAT
PATCr
110-1-1-1200-1-10
Growth YoY
PAT Growth YoY%
100.0148.2-117.1-185.5-262.0-213.43,285.7107.5101.218.4-136.8350.0
NPM
NPM%
1.61.7-0.2-1.3-5.8-6.815.60.30.1-7.0-6.31.1
EPS
EPS
0.60.8-0.1-0.6-0.9-0.92.60.10.0-0.1-0.80.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1922272423487383128784449
Growth
Revenue Growth%
14.418.422.9-9.6-6.0111.050.913.354.8-39.0-43.1-4.1
Expenses
ExpensesCr
1721262322446978122744246
Operating Profit
Operating ProfitCr
111214456423
OPM
OPM%
6.35.14.96.86.18.15.66.24.55.15.55.1
Other Income
Other IncomeCr
000000100000
Interest Expense
Interest ExpenseCr
111113333333
Depreciation
DepreciationCr
000000011111
PBT
PBTCr
0000011220-1-1
Tax
TaxCr
000000011000
PAT
PATCr
0000011120-1-1
Growth
PAT Growth%
22.441.07.7101.8-80.0600.939.729.331.4-88.8-749.2-278.6
NPM
NPM%
0.81.00.91.90.41.41.31.41.20.2-2.5-2.6
EPS
EPS
0.40.50.51.10.20.41.11.41.80.2-1.2-0.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1922272423487383128784449
Growth
Revenue Growth%
14.418.422.9-9.6-6.0111.050.913.354.8-39.0-43.1-4.1
Expenses
ExpensesCr
1721262322446978122744246
Operating Profit
Operating ProfitCr
111214456423
OPM
OPM%
6.35.14.96.86.18.15.66.24.55.15.55.1
Other Income
Other IncomeCr
000000100000
Interest Expense
Interest ExpenseCr
111113333333
Depreciation
DepreciationCr
000000011111
PBT
PBTCr
0000011220-1-1
Tax
TaxCr
000000011000
PAT
PATCr
0000011120-1-1
Growth
PAT Growth%
22.441.07.7101.8-80.0600.939.729.331.4-88.8-749.2-278.6
NPM
NPM%
0.81.00.91.90.41.41.31.41.20.2-2.5-2.6
EPS
EPS
0.40.50.51.10.20.41.11.41.80.2-1.2-0.8

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
444449999911
Reserves
ReservesCr
-3-3-3-2-23456714
Current Liabilities
Current LiabilitiesCr
778810353835424638
Non Current Liabilities
Non Current LiabilitiesCr
66544656777
Total Liabilities
Total LiabilitiesCr
1314151516525555646770
Current Assets
Current AssetsCr
10810911404443525455
Non Current Assets
Non Current AssetsCr
46555121112131315
Total Assets
Total AssetsCr
1314151516525555646770
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
444449999911
Reserves
ReservesCr
-3-3-3-2-23456714
Current Liabilities
Current LiabilitiesCr
778810353835424638
Non Current Liabilities
Non Current LiabilitiesCr
66544656777
Total Liabilities
Total LiabilitiesCr
1314151516525555646770
Current Assets
Current AssetsCr
10810911404443525455
Non Current Assets
Non Current AssetsCr
46555121112131315
Total Assets
Total AssetsCr
1314151516525555646770

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-21-111-2363-4-3
Investing Cash Flow
Investing Cash FlowCr
0-10-1000-2-2-10
Financing Cash Flow
Financing Cash FlowCr
1-11-1-11-3-4-264
Net Cash Flow
Net Cash FlowCr
-10000001011
Free Cash Flow
Free Cash FlowCr
-20-111-2342-5-3
CFO To PAT
CFO To PAT%
-1,160.8527.7-265.2296.71,301.8-263.7349.6504.4222.8-2,112.1232.2
CFO To EBITDA
CFO To EBITDA%
-152.7100.9-46.883.587.3-44.277.9116.659.8-92.5-107.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-21-111-2363-4-3
Investing Cash Flow
Investing Cash FlowCr
0-10-1000-2-2-10
Financing Cash Flow
Financing Cash FlowCr
1-11-1-11-3-4-264
Net Cash Flow
Net Cash FlowCr
-10000001011
Free Cash Flow
Free Cash FlowCr
-20-111-2342-5-3
CFO To PAT
CFO To PAT%
-1,160.8527.7-265.2296.71,301.8-263.7349.6504.4222.8-2,112.1232.2
CFO To EBITDA
CFO To EBITDA%
-152.7100.9-46.883.587.3-44.277.9116.659.8-92.5-107.6

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2410635423661354851
Price To Earnings
Price To Earnings
11.419.843.612.536.416.145.930.339.0204.7
Price To Sales
Price To Sales
0.10.20.40.20.10.10.60.40.50.51.11.1
Price To Book
Price To Book
1.73.56.93.01.70.93.42.64.02.31.92.0
EV To EBITDA
EV To EBITDA
5.78.513.38.07.87.816.311.714.716.830.730.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
15.918.114.318.719.620.913.513.29.313.420.820.8
OPM
OPM%
6.35.14.96.86.18.15.66.24.55.15.55.1
NPM
NPM%
0.81.00.91.90.41.41.31.41.20.2-2.5-2.6
ROCE
ROCE%
15.417.212.114.211.210.410.912.612.67.23.33.3
ROE
ROE%
15.117.915.824.24.75.77.48.810.41.1-4.5-4.5
ROA
ROA%
1.21.61.53.20.61.31.62.12.40.3-1.6-1.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2410635423661354851
Price To Earnings
Price To Earnings
11.419.843.612.536.416.145.930.339.0204.7
Price To Sales
Price To Sales
0.10.20.40.20.10.10.60.40.50.51.11.1
Price To Book
Price To Book
1.73.56.93.01.70.93.42.64.02.31.92.0
EV To EBITDA
EV To EBITDA
5.78.513.38.07.87.816.311.714.716.830.730.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
15.918.114.318.719.620.913.513.29.313.420.820.8
OPM
OPM%
6.35.14.96.86.18.15.66.24.55.15.55.1
NPM
NPM%
0.81.00.91.90.41.41.31.41.20.2-2.5-2.6
ROCE
ROCE%
15.417.212.114.211.210.410.912.612.67.23.33.3
ROE
ROE%
15.117.915.824.24.75.77.48.810.41.1-4.5-4.5
ROA
ROA%
1.21.61.53.20.61.31.62.12.40.3-1.6-1.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Axel Polymers is a specialist plastics compounder - it takes base engineering polymers, melts and mixes them with additives, and turns them into high-performance pellets that manufacturers can mould directly into finished parts. Founded in 1992 and listed on the Bombay Stock Exchange, the company has spent three decades building what it claims is India's largest operation in engineering thermoplastic compounds, serving multinationals and domestic corporates alike. Its recurring approach is to compete on formulation expertise rather than scale: it develops its own grades in-house, runs a single focused plant in Gujarat, and sells to industrial customers who need plastics that can withstand heat, impact or electrical stress - the kind of work where knowing the recipe matters more than having the biggest factory. # Business segments A single-engine business - one plant, one core manufacturing process, one customer type - built entirely around custom-formulated engineering plastic compounds. ## 1. Engineering thermoplastic compounds: the company's entire business **It buys raw polymer resins, mixes them with additives on twin-screw extruders, and sells the resulting compound pellets to manufacturers who need plastics that do things ordinary plastics cannot.** - **Four industry sectors, one technology** - the product range is organised by end-use into Water Management, Engineering Industry, Electrical & Electronics, and Automotive, and also reaches home appliances, construction, packaging and healthcare. Every sector draws on the same underlying skill: blending engineering polymers into compounds, blends and alloys with specific mechanical, thermal or electrical properties. - **Formulation is the factory's real product** - the company emphasises in-house technology development and advanced R&D skills, with a quality-control system built around developing, producing and delivering products that conform to each customer's requirements. The Managing Director, an engineer with two decades in plastics, personally led the launch of the company's own brand of thermoplastic compounds and built the client roster across sectors. - **Twin-screw extruders do the heavy lifting** - the key production equipment is twin-screw extruders, which the company assigns a useful life of 20 years based on independent technical evaluation, roughly two and a half times the eight-year life it assigns to other plant and machinery. That long-life assumption signals how central and durable these machines are to the operation. - **A single plant in Gujarat serves everyone** - all manufacturing happens at one facility on the Sankarda-Savli Road in Vadodara district, which also serves as the registered office, while a corporate office in Mumbai handles commercial functions. The plant produced about 2,926 metric tonnes of compounds in FY25, down from roughly 4,912 metric tonnes the year before, reflecting the demand swings the business works with. - **Mostly manufacturing, with a side of trading** - the company sells its own manufactured compounds (3,123 metric tonnes in FY25), trades small volumes of engineering polymers and compatibilisers (76 metric tonnes in FY25), and has wound down toll compounding - making compounds on behalf of others - to zero over the past three years. The shift away from toll work suggests a deliberate focus on its own-brand business. # Group structure and partners **Axel Polymers is a stand-alone company with no subsidiaries or joint ventures, but its history and operations are intertwined with entities linked to its Managing Director.** - **A manufacturing agreement with a related partnership** - the company has a Manufacturing, Purchase & Sales Agreement with V.R. Industries, a partnership in which the Managing Director is a partner, covering the buying, selling or manufacturing of engineering polymer compounds for both domestic and export markets. The current agreement runs from October 2023 to September 2026 with an annual transaction cap of ₹15 crore, replacing an earlier three-year agreement capped at ₹10 crore per year. - **The office is rented from the MD** - the Mumbai corporate office operates from premises leased from the Managing Director under a 36-month Leave and License Agreement that began in September 2021, with rent stepping up from ₹3 lakh to ₹3.3 lakh per month after the first year.

Documents — Axel Polymers Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/xj9cfzrbvhcj1ldp9snknu29.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/0hyoa6jv5gdsi0ztyqa1utuu.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/rel26ftmtfbryxgve3yhtr6p.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/nxt031njgvtn3lnd0vkq10mx.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/hiqlwtxzskxzvs12zphhhdua.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/ix39949hkodqxzx56b2uqhrd.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/rey1sxgic7bu8oid8677fkj1.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/ybdhx1xugz67h7xq5ctu7csj.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/t7nwilu5c0z4yu8xczhtubhn.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/6zbvou763et3rmmk33q68wlb.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/d1ghokqerr6fov0uuhnmcgi2.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/9yoyqtequje3xlwfeaaqmlnq.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/9oj26sdl3i1pom0t8t59zl7j.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/8yyyh1bf0z8b7dr30tvw8q9c.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/5g3mbldlqsdd341zlmprp3jz.pdf